Skip to main content

Strict Liability Claims Against Pelvic Mesh Manufacturer

Strict Liability Claims Against Pelvic Mesh Manufacturer

Strict Liability Claims Against Pelvic Mesh Manufacturer

Introduction

The U.S. District Judge Michael Baylson of the Eastern District of Pennsylvania allowed strict liability claims to proceed against Coloplast Corp. in a pelvic mesh case.

The lawsuit was filed by a woman and her husband, against the pelvic mesh manufacturer, in 2018 over its allegedly defective device. The plaintiffs raised eight claims, including three based on strict liability.

According to a motion filed, Coloplast attempted to extend protections provided to the makers of prescription medical devices under comment K to Section 402 of the Restatement (Second) of Torts, citing the 2006 Pennsylvania Supreme Court decision in Creazzo v. Medtronic. But in Jan. 17 order, the judge denied the company’s motion to dismiss for failure to state a claim on the strict liability issues. The judge also noted that the U.S. Food and Drug Administration initially approved the device, but ordered the company to stop selling it in April 2019.

The Pennsylvania Supreme Court advised the judges to not make categorical decisions about products concerning liability, without a strong record on the policy issues that should inform a common-law analysis of whether to allow these claims.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Teen E-cigarette Use Hits 10-Year Low

Categories: E-Cigarette: JUUL

Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Categories: Opioids

The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…

Drug Distributors Reach $300M Opioid Settlement

Categories: Opioids

The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…

Labor Day Litigation Bonanza!     
Free Trials + 15% Discount!